Cargando…

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients

Detalles Bibliográficos
Autores principales:	Vasu, Sujethra, Bandettini, W Patricia, Hsu, Li-Yueh, Kellman, Peter, Chen, Marcus Y, Wilson, Joel, Leung, Steve, Shanbhag, Sujata M, Booker, O Julian, Mancini, Christine, Henry, Jennifer, Lowrey, Tracy, Arai, Andrew E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106792/ http://dx.doi.org/10.1186/1532-429X-13-S1-P124

Ejemplares similares

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
por: Bandettini, W Patricia, et al.
Publicado: (2012)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Heterogeneity of resting and hyperemic myocardial blood flow in healthy volunteers: a quantitative CMR perfusion pixel-map study
por: Greve, Anders M, et al.
Publicado: (2014)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study(†)
por: Hammer-Hansen, Sophia, et al.
Publicado: (2016)

Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2018)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Image quality and diagnostic accuracy of inline motion-corrected (moco) first-pass stress myocardial perfusion images
por: Shanbhag, Sujata M, et al.
Publicado: (2011)

Differential effect of regadenoson versus dipyridamole on heart rate in patients with left bundle branch block: How does it affect the results of pharmacological nuclear stress testing?
por: Assaad, Mahmoud, et al.
Publicado: (2019)

The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers
por: El Messaoudi, S., et al.
Publicado: (2016)

High prevalence of atypical delayed enhancement in alkaptonuria
por: Chen, Marcus Y, et al.
Publicado: (2014)

Interobserver reproducibility of fully quantitative pixel-wise analysis of clinical CMR perfusion imaging
por: Conn, Hannah, et al.
Publicado: (2014)

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
por: Kellman, Peter, et al.
Publicado: (2012)

Organisation: Voluntary, or Compelled?
Publicado: (1918)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Contributing Chemistry and Compelling Physics
Publicado: (2013)

Is the Act of Compelling Vaccination Unconstitutionial?
por: Wyatt, Thomas M.
Publicado: (1892)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques
por: Kellman, Peter, et al.
Publicado: (2015)

Livedoid vasculopathy: a compelling diagnosis
por: Freitas, Thiago Quadrante, et al.
Publicado: (2018)

Mitophagy and Neuroinflammation: A Compelling Interplay
por: Charmpilas, Nikolaos, et al.
Publicado: (2023)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

A comparison of cine CMR imaging at 0.55 T and 1.5 T
por: Bandettini, W. Patricia, et al.
Publicado: (2020)

Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis
por: Ta, Allison D., et al.
Publicado: (2018)

Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson
por: Bitar, Abbas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o7eeo3rjv9mg1aib9ej416n6gc